Vascular Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Vascular Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Vascular Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. Vascular Grafts are the implants used to repair, bypass or replace sections of blood vessels during surgical procedures. They are also used to patch injured or diseased areas in the arteries and for the replacement of whole segments of larger arteries such as the aorta.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Vascular Grafts under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Vascular Grafts under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Vascular Grafts Overview
Products under Development
Vascular Grafts - Pipeline Products by Stage of Development
Table Vascular Grafts - Pipeline Products by Stage of Development
Table Vascular Grafts - Pipeline Products by Stage of Development
Vascular Grafts - Pipeline Products by Segment
Table Vascular Grafts - Pipeline Products by Segment
Table Vascular Grafts - Pipeline Products by Segment
Vascular Grafts - Pipeline Products by Territory
Table Vascular Grafts - Pipeline Products by Territory
Table Vascular Grafts - Pipeline Products by Territory
Vascular Grafts - Pipeline Products by Regulatory Path
Table Vascular Grafts - Pipeline Products by Regulatory Path
Table Vascular Grafts - Pipeline Products by Regulatory Path
Vascular Grafts - Pipeline Products by Estimated Approval Date
Table Vascular Grafts - Pipeline Products by Estimated Approval Date
Table Vascular Grafts - Pipeline Products by Estimated Approval Date
Vascular Grafts - Ongoing Clinical Trials
Table Vascular Grafts - Ongoing Clinical Trials
Table Vascular Grafts - Ongoing Clinical Trials
Vascular Grafts - Pipeline Products under Development by Companies
Vascular Grafts Companies - Pipeline Products by Stage of Development
Table Vascular Grafts Companies - Pipeline Products by Stage of Development
Vascular Grafts - Pipeline Products by Stage of Development
Table Vascular Grafts - Pipeline Products by Stage of Development
Table Human Acellular Vessel - Vascular Trauma - A Compassionate Use Study of Humacyte's Human Acellular Vessel for the Treatment of Patients with Critical Limb Ischemia and Vascular Trauma
Table Human Acellular Vessel - Vascular Trauma - A Phase 2/3 Study for the Evaluation of Safety and Efficacy of Humacytes Human Acellular Vessel for Vascular Replacement or Reconstruction in Patients with Life or Limb-threatening Vascular Trauma
Table Human Acellular Vessel - Vascular Trauma - An Observational Multicenter Study to Evaluate the Safety and Efficacy of Humacyte's Human Acellular Vessel in a Real World Setting for Arterial Replacement or Reconstruction in Ukrainian Patients with Life or Limb-threatening Vascular Trauma
Table Second-Generation Tissue Engineered Vascular Graft - Prospective, Open-labelled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection
Northwestern University Company Overview
Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Table Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Table ePTFE Graft - Peripheral Arterial Disease - Product Status
Table TORUS Stent Graft System - The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization - 2 Trial: TORUS 2
Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview
Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table TIPS Stent Graft System - Product Status
Table TIPS Stent Graft System - Product Description
Table Shanghai MicroPort Endovascular MedTech Group Co Ltd - Ongoing Clinical Trials Overview
Table TIPS Stent Graft System - A Prospective, Multicenter, Single-group, Target-value Trial to Evaluate the Safety and Efficacy of Tips Coated Stent System in the Treatment of Portal Hypertension
Southern University of Science and Technology Company Overview
Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
Table Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
Yale University Pipeline Products & Ongoing Clinical Trials Overview
Table Yale University Pipeline Products & Ongoing Clinical Trials Overview
Table Human iPSC-based Tissue Engineered Vascular Graft - Product Status
Table Human iPSC-based Tissue Engineered Vascular Graft - Product Description
Vascular Grafts- Recent Developments
May 22, 2024: MicroPort Announces Board and Committee Lineup
Apr 13, 2024: Atrium Medical Receives Additional FDA 510(k) Clearance for Flixene IFG Vascular Grafts With Assisted Delivery
Apr 10, 2024: Atrium Medical Receives FDA 510(k) Clearance for Advanta VXT Vascular Graft
Mar 19, 2024: PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis
Mar 18, 2024: Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System
Mar 11, 2024: W. L. Gore & Associates Receives Additional 510(K) Clearance For GORE PROPATEN Vascular Graft
Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
Feb 09, 2024: Human Acellular Vessel (HAV) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
Jan 29, 2024: W. L. Gore & Associates Additional 510(K) Clearance For GORE PROPATEN Vascular Graft
Jan 29, 2024: Peca Labs Receives Additional FDA 510(k) Clearance for exGraft ePTFE Vascular Graft
Jan 29, 2024: Peca Labs Receives Additional 510(K) Clearance For exGraft Carbon ePTFE Vascular Graft
Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
Dec 20, 2023: RUA Life Sciences : Heart Valve Leaflet Material - Testing Update
Dec 12, 2023: Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel (HAV) for the Treatment of Vascular Trauma
Nov 20, 2023: RUA Life Sciences Announces Strategy Update
Nov 17, 2023: Humacyte Announces Two Presentations at the VEITHsymposium of Positive Clinical Results of the Human Acellular Vessel (HAV) in the Treatment of Vascular Trauma
Nov 10, 2023: Microport Appointment of Director
Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
Oct 19, 2023: Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
Sep 18, 2023: Humacyte to Host In-Person Kol Event at the New York Edition on September 20, 2023
Sep 12, 2023: Humacyte Announces Positive Top Line Results from Phase 2/3 Trial of Human Acellular Vessel (HAV) in Treatment of Patients with Vascular Trauma
Sep 11, 2023: Results From Mayo Clinic Clinical Study of Humacyte's Human Acellular Vessel (HAV) in Treatment of Patients with Chronic Limb Ischemia Presented at Midwestern Vascular Conference
Sep 11, 2023: Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial in Vascular Trauma Evaluating its Human Acellular Vessel (HAV) Tuesday, September 12, 2023 at 8:00 AM ET
Aug 23, 2023: Aquedeon Medical, Receives FDA IDE Approval For The Duett Vascular Graft System
Aug 15, 2023: Humacyte Presents Clinical Performance of Human Acellular Vessel (HAV) From Ukrainian Humanitarian Program
Aug 11, 2023: W. L. Gore & Associates to Present New Mosa Paper At Gvsets Conference
Aug 03, 2023: Humacyte Announces Publication of Biological Mechanism Explaining Low Rates of Infection Observed in Clinical Study of Human Acellular Vessel (HAV)
Jul 26, 2023: Humacyte Completes Enrollment in Phase 2/3 Trial of Human Acellular Vessel (HAV) for Vascular Trauma Repair
Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023